Recent Updates
Recently added Catalysts

Sertraline

Phase 1

Healthy | Small molecule | Other |Viatris Inc.|Last Updated: Apr 24, 2024

Success Probability

Subscribe to view

Market & Valuation

Subscribe to view

Trial Design

RandomizedACTIVE_CONTROLLEDBiomarker
Total Trials2
Total Enrollment70

FDA Designations

No designations recorded

Clinical trial landscape

Sertraline · 2 trials · 1 indication

Phase 1 2
NCT00648856Food Study of Sertraline Hydrochloride Tablets 100 mg and Zoloft® Tablets 100 mgHealthy
COMPLETED21 Analytics
NCT00650325Study of Sertraline Hydrochloride Tablets 100 mg and Zoloft® Tablets 100 mgHealthy
COMPLETED49 Analytics
PHASE1COMPLETED
Food Study of Sertraline Hydrochloride Tablets 100 mg and Zoloft® Tablets 100 mg
HealthyUnlock trial analytics
PHASE1COMPLETED
Study of Sertraline Hydrochloride Tablets 100 mg and Zoloft® Tablets 100 mg
HealthyUnlock trial analytics

Study Endpoints

Primary Endpoints

Bioequivalence
within 30 days
Unlock Study Endpoints

Study Design & Arms

AllocationRANDOMIZED
MaskingNONE
ModelCROSSOVER
PurposeOTHER

Treatment Arms

ArmTypeDescription
1EXPERIMENTALSertraline Hydrochloride Tablets 100 mg
2ACTIVE_COMPARATORZoloft® Tablets 100 mg

Interventions

NameTypeDescription
Sertraline Hydrochloride Tablets 100 mgDRUG100mg, single dose fed
Zoloft® Tablets 100 mgDRUG100mg, single dose fed
Unlock Study Design Details

Eligibility Criteria

Age Range18 Years to N/A
SexALL
Healthy VolunteersYes
Study Sites1

Inclusion Criteria: 1. Age: 18 years and older. 2. Sex: Male and/or non-pregnant, non-lactating female. 1. Women of childbearing potential must have negative serum beta-human chorionic gonadotropin (HCG) pregnancy tests performed within 14 days prior to the start of the study and on the evening...

Countries:United States
Unlock Eligibility Criteria